DeviceSignal · Recall classified

Siemens Healthcare Diagnostics, Inc.

FDA classified a device recall on 2026-08-05 · Class II · Z-2890-2026

EventRecall classified
Effective2026-08-05
ClassificationClass II

On 2026-08-05 the FDA classified a device recall from Siemens Healthcare Diagnostics, Inc. as Class II. Product: Atellica CH Urine Albumin REF: 11537225, in vitro diagnostic. Recall Z-2890-2026. The firm initiated it on 2026-07-06. This reports the classification FDA published on that date.

Reported facts

Recall number
Z-2890-2026
Classification
Class II
Classified on
2026-08-05
Initiated on
2026-07-06
Firm
Siemens Healthcare Diagnostics, Inc.
Reason
Processing of urine albumin assay on the CI analyzers may lead to the following issues: Falsely depressed Atellica CH Urea Nitrogen (UN_c) results; Falsely depressed Atellica CH Enzymatic Hemoglobin A1c (A1c_E) results; Increased rate of reaction cuvette QC failures and Delayed results due to QC failures.
Product
Atellica CH Urine Albumin REF: 11537225, in vitro diagnostic

Every field above is as fda_device_enforcement published it. Nothing on this page is our interpretation.

Provenance

Source
fda_device_enforcement
Source record
Z-2890-2026
Snapshot hash
ab5ada73bf212eb52a548aab0968a0fcee42807c61b0350e60e24bb6e2beed72
Source URL
https://download.open.fda.gov/device/enforcement/device-enforcement-0001-of-0001.json.zip
Observed
2026-09-08T16:22:09.483Z
Transform
fda_device_enforcement_to_recall v1
Event rule
fda_device_recall_classified v1
Event key
6bf64a05a310156d1be98db173bdefca04fb19c03ed84479de912785398b0fe0
Signal type
device_recall.classified

Source terms that apply

More DeviceSignal signals What DeviceSignal is

Data provided by the U.S. Food and Drug Administration (https://open.fda.gov)